Evidence map›Paper›PMID 35736449›Full record

ReviewMetabolites2022

KIAA1363-A Multifunctional Enzyme in Xenobiotic Detoxification and Lipid Ester Hydrolysis.

Carina Wagner, Victoria Hois, Ulrike Taschler, Michael Schupp, Achim Lass

Open access · goldAbstract readReview
In one paragraph

Review in Metabolites, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Carina WagnerInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria.
Victoria HoisDivision of Endocrinology and Diabetology, Medical University of Graz, 8036 Graz, Austria.
Ulrike TaschlerInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria.ORCID 0000-0001-9000-1602
Michael SchuppCardiovascular Metabolic Renal (CMR)-Research Center, Institute of Pharmacology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10115 Berlin, Germany.ORCID 0000-0003-3720-1052
Achim LassInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-8190-7151
University of Graz · ATHumboldt-Universität zu Berlin · DEMedical University of Graz · AT

Funding

Austrian Science Fund FWF I 3535Austrian Science Fund FWF P 31638Austrian Science Fund FWF P 34899Deutsche Forschungsgemeinschaft SCHU 2546/5-1FWF Austrian Science Fund I3535FWF Austrian Science Fund P31638FWF Austrian Science Fund P34899
6 · The paper itself

Abstract

KIAA1363, annotated as neutral cholesterol ester hydrolase 1 (NCEH1), is a member of the arylacetamide deacetylase (AADAC) protein family. The name-giving enzyme, AADAC, is known to hydrolyze amide and ester bonds of a number of xenobiotic substances, as well as clinical drugs and of endogenous lipid substrates such as diglycerides, respectively. Similarly, KIAA1363, annotated as the first AADAC-like protein, exhibits enzymatic activities for a diverse substrate range including the xenobiotic insecticide chlorpyrifos oxon and endogenous substrates, acetyl monoalkylglycerol ether, cholesterol ester, and retinyl ester. Two independent knockout mouse models have been generated and characterized. However, apart from reduced acetyl monoalkylglycerol ether and cholesterol ester hydrolase activity in specific tissues and cell types, no gross-phenotype has been reported. This raises the question of its physiological role and whether it functions as drug detoxifying enzyme and/or as hydrolase/lipase of endogenous substrates. This review delineates the current knowledge about the structure, function and of the physiological role of KIAA1363, as evident from the phenotypical changes inflicted by pharmacological inhibition or by silencing as well as knockout of KIAA1363 gene expression in cells, as well as mouse models, respectively.

Indexed as

arylacetamide deacetylase-like 1KIAA1363lipid metabolismneutral cholesterol ester hydrolase 1xenobiotics

Identifiers

PMID35736449
PMCPMC9229287
OpenAlexW4281668941

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.